Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL

Biomedical Reports

ISSN 2049-9434 · eISSN 2049-9442 · Spandidos Publications

Biomedical Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.5 (journal website); fully open access; median 143 days to acceptance (103 articles, last 24 months); 181 articles in 2025; indexed in ESCI and Scopus.

Impact factor2.5From the journal's website, latest value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time143 daysMedian, submission to acceptance · 103 articles, last 24 months · PubMed
APC—No source gives fee information
Acceptance—No reports yet
Articles per year1812025 · OpenAlex count

Scope

Aims, scope and focus

Biomedical Reports is published by Spandidos Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are MicroRNA in disease regulation, Liver Disease Diagnosis and Treatment and Cancer-related molecular mechanisms research, together about 26.1% of its articles. Its main subfields are Cancer Research and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

From the journal's Aims & Scope

Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL

Editor-in-chief DEMETRIOS A. SPANDIDOSPublisher website

Editorial board by country: none in mainland China; most named Italy 6, Japan 5, Greece 4, Saudi Arabia 3, United Kingdom 2 (26 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology9.5%
  2. Liver Disease Diagnosis and TreatmentMedicine8.3%
  3. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology8.3%
  4. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.9%
  5. Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.2%
  6. Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology4.8%
  7. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology3.7%
  8. Adipokines, Inflammation, and Metabolic DiseasesMedicine3.6%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, Research & ExperimentalZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, Research & ExperimentalZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
2.5Publisher website ·
CiteScore 2026-06
3.6LetPub ·
CiteScore (publisher)
3.6Publisher website ·
SJR 2026-06
0.62LetPub ·
SNIP 2026-06
0.76LetPub ·
h-index
65OpenAlex ·
i10-index
957OpenAlex ·
2-year mean citedness
3.51OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
194LetPub ·

Articles by year OpenAlex count · 2,203 in total · the current year is incomplete

YearArticlesOpen accessCitations
202610810832
2025181181484
20242002001,202
2023122122968
2022100100916
202193931,865

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

143 daysMedian, submission to acceptance · P25–P75 97 days – 186 days

Acceptance to online
median 32 days (103 articles)
Submission to online
median 184 days
Sample
103 articles with submission and acceptance dates (366 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

No source has fee information yet; check the journal's website.

Other charges and waivers (author guidelines)

Page charges
EUR 110
Submission fee
EUR 550

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare5 items from the author guidelines
Abstract
150–300 words
Keywords
5–10
Reference style
Numbered, in order of citation
Cover letter
Required
Not considered
Footnotes; Page numbers or line numbers; Page breaks or multiple returns between sections
Publisher website · model-extracted, each line checked against the text
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, License & copyright, Open access, Self-archiving
AI use Use of artificial intelligence tools

Authors should disclose the use of artificial intelligence (AI)-assisted tools such as chatGPT in the Declarations section (e.g. ‘Use of artificial intelligence tools - During the preparation of this work, AI tools were used to improve the readability and language of the manuscript or to generate images, and subsequently, the authors revised and edited the content produced by the AI tools as neces…

Source ↗Publisher website ·
Conflicts of interest Competing interests

Authors, reviewers and editors must disclose any competing interests that may exist with respect to the publication of a study. Competing interests are at play if the interpretation and presentation of the data, the conclusions or any other information provided by the authors can be influenced (or may be perceived as such) by their personal or financial relationship with other individuals or organ…

Source ↗Publisher website ·
Data availability Availability of data and materials

For all manuscripts submitted to Spandidos Publications, the authors must make provisions for all materials described in the study, including all relevant raw data, to be freely available to any researchers who may wish to use them for non-commercial purposes, while preserving confidentiality and anonymity. If any conclusions made in the paper depend on a particular, dataset, then this dataset mus…

Source ↗Publisher website ·
License & copyright 3.3.9 Copyright

If a figure or table has been published previously (even if you were the author of the manuscript), copyright permission for re-use of the figure or table will often be required. You must acknowledge the original source and submit written permission from the copyright holder to reproduce the material where necessary. As an author of your manuscript, you are responsible for obtaining permissions to…

Source ↗Publisher website ·
Open access 7. Open access

"Open access" articles published online can be freely accessed at the journal's website by all users. The articles are made immediately available as Open access and appear online at PubMed, PubMed Central and Europe PMC. Articles may be licensed under a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International License, a Creative Commons Attribution-NonCommercial 4.0 Internationa…

Source ↗Publisher website ·
Self-archiving 10. Author self-archiving

Authors are encouraged to submit the final publisher’s version PDF of their manuscript to their institution’s repository 6 months following publication, as well as to their funding body’s archive. A link to the published version on the Spandidos Publications website must be included with full citation details and acknowledgement of the journal as the original source. Authors that have purchased Op…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Spandidos Publications
ISSN
2049-9434
Electronic ISSN
2049-9442
Official links

FAQ

Frequently asked questions about Biomedical Reports

What CAS zone is Biomedical Reports in?

In the 2025 upgraded edition of the CAS Journal Ranking, Biomedical Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Biomedical Reports?

The journal's website gives an impact factor of 2.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.6, h-index 65.

How long does peer review take at Biomedical Reports?

Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 143 days (interquartile range 97–186 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Biomedical Reports?

According to the journal's author guidelines: Abstract: 150–300 words; Keywords: 5–10; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Biomedical Reports based?

Of the 26 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (6), Japan (5) and Greece (4). Counted from the institutions listed on the board page; for reference only.

Which databases index Biomedical Reports?

According to LetPub and DOAJ records, Biomedical Reports is indexed in ESCI and Scopus.

Is Biomedical Reports open access, and what is the APC?

Biomedical Reports is a fully open-access journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .